Alzheimer's disease (AD) is a devastating neurodegenerative disorder manifested by deterioration in memory and cognition, impairment in performing activities of daily living, and many behavioral and neuropsychiatric illnesses.
Introduction
ALZHEIMER'S disease (AD) is a severe progressive neurodegenerative brain disorder that affects approximately 5% of the population older than 65 years [1] . It was first described by Alois Alzheimer
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Role of Estrogen Hormone in Lipopolysaccharide-Induced more than a century ago in Germany, and it constitutes one of the most common causes of senile dementia. According to a previous estimation, it is possible that almost 80% of individuals with dementia suffer from AD [2] .
The clinical manifestations of AD include the progressive deterioration of episodic memory and other intellectual abilities, leading to global cognitive decline, behavioral and psychiatric symptoms and personality changes. Most AD cases begin after 65 years old (i.e. late-onset AD). However, some cases manifest in younger subjects (i.e. earlyonset AD) [3] .
Pathologically, AD is characterized by senile plaques due to abnormal accumulation of extracellular amyloid ß (Aß) and the intracellular neurofibrillary tangles (NFTs) which are responsible for the neuronal loss, degeneration of cholinergic system [4] , oxidative damage, synaptic dysfunction and inflammation [5] .
Estrogens are the primary female sex hormones and play important roles in both reproductive and non-reproductive systems [6] . Originally identified as reproductive hormones, estrogens are now generally thought to play an important role in bone, cardiovascular system and in the central nervous system [7] . They promote the development of female secondary sexual characteristics, decelerate height growth, accelerate metabolism (burn fat), reduce muscle mass, stimulate endometrial growth, increase uterine growth, increase vaginal lubrication, thicken the vaginal wall, maintenance of vessel and skin, reduce bone resorption and increase bone formation [8, 9] . Estrogens exert many actions on brain areas that are important for learning, memory, emotions, and affective state as well as motor coordination and pain sensitivity [10] .
The incidence of AD is higher in women than in men and the progression of this disease has different features in the two sexes [11] . The precipitous loss of ovarian estrogens and progestogens at menopause has been presumed to account for the increased female susceptibility to AD [12] .
Aim of the work:
The present study is designed to investigate the behavioral, biochemical and histological changes in lipopolysaccharide (LPS)-induced AD. Also, to study effect of estrogen hormone in AD and to clarify the possible underlying mechanisms involved in this effect. Furthermore, the possible modulation of this estrogen effect by progesterone hormone was studied with the aim of establishing a mechanism that may aid in AD treatment.
Material and Methods

Experimental animals:
A total of 50 female albino rats weighing between 150-200gm were used in this study. Animals were purchased from the Animal House of Faculty of Medicine, Cairo University, they were housed in plastic cages at room temperature with normal light and dark cycles and were allowed to acclimatize to their environment for one week before start of the experiment. All animals were under the same environmental conditions and had free access to food and water.
Experimental protocol:
The animals were divided into five groups 10 rats each.
Group I: (Control group):
This group Included the control (sham-operated) rats. Animals of this group were trained according to the training protocol. At the end of training sessions, behavioral assessment at zero time was done. Animals then were sham operated. Four weeks after sham operation, they were injected with a single dose of saline 0.8mg/kg i.p. then they were left till the end of the experimental protocol of 6 weeks.
Group II: (AD group):
Animals of this group were trained according to the training protocol. At the end of training sessions, behavioral assessment at zero time was done. Four weeks after, AD was induced in this group by injecting them with a single dose of LPS 0.8mg/kg i.p. [13] . Animals were left till the end of the experimental protocol of 6 weeks.
Group III: (AD+ Ovariectomy (O VX) group):
Animals of this group were trained according to the training protocol. At the end of training sessions, behavioral assessment at zero time was done, and then animals underwent bilateral OVX. Four weeks after OVX, AD was induced as in group II. Animals were left till the end of the experimental protocol of 6 weeks.
Group IV: (AD+ O VX+ estrogen replacement group):
Animals in this group were trained, OVX was done and AD was induced as in group III. One week after LPS injection, animals were treated with estrogen supplementation (Estradiol 0. 1 mg/kg i.p.) daily for 1week [14] .
Group V: (AD+ O VX+ estrogen and progesterone replacement group):
Animals in this group were trained, OVX was done and AD was induced as in group III. One week after LPS injection, animals were treated with estrogen supplementation (Estradiol 0. 1 mg/kg i.p.) and progesterone supplementation (10mg/kg i.p.) daily for 1 week [14] .
In all groups, after 6 weeks, behavioral tests were repeated for the second time to assess levels of activity, motor coordination and cognitive abilities. This was followed by sample collection and animal sacrifice.
Sample collection and animal sacrifice:
Immediately before sacrifice, blood samples were taken from retroorbital vein then left to clot for 15 minutes and centrifuged at 10,000 round per minute (rpm) for 20 minutes then separated serum was kept frozen at -70ºC till analysis of TNF-(x . The animals were then sacrificed using lethal dose of ether. The brain specimens were removed then divided into three parts: First part was examined for gene expression and it was kept in lysis solution for RNA extraction, second part was assessed for malondialdehyde (MDA) level and it was kept in phosphate buffer saline and the third part was fixed in 10% formol saline for 48 hours. Paraffin blocks were prepared and 5 g m thick sections of the frontal lobes were subjected to histological, histochemical, immunohistochemical and morphometric study.
At the end of experimental protocol of 6 weeks, the following parameters were assessed: I-Behavioral assessment:
The following parameters were assessed at zero time and at the end of the experimental protocol of 6 weeks. The percentage of final measurement from zero time measurement was calculated (% change).
-Measurement of levels of activity using the activity cage test.
-Measurement of motor coordination using the rotarod test.
-Test for cognitive abilities using T-maze.
II-Biochemical and gene expression tests:
-Determination of TNF-(x level in serum (proinflammatory marker).
-Estimation of estrogen receptor-(x , Bcl-2 (antiapoptotic marker) and selective AD indicator-1 (Seladin-1) gene expression in brain tissue.
-Estimation of the levels of MDA in brain tissue (biomarker of oxidative stress).
III-Histological and morphometric studies:
-Histological study: Hematoxylin and eosin.
-Histochemical study: Congo red stain.
-Immunohistochemical study for estrogen receptor.
-Morphometric study.
Surgical procedures:
Ovariectomy:
After anesthesia with injection of ketamine (30mg/kg i.p.) and xylazine (3mg/kg i.p.), female rats underwent skin incision of 1 to 1.5cm, muscular incision was done to open the peritoneal cavity for posterior connection of uterine tubules and removal of the ovaries. The peritoneal cavity was then sutured and cleaned with gentamycin ointment [15] .
Sham operation:
The rats were exposed to the same procedure as ovariectomy but without removal of the ovaries.
Procedures of the different studied parameters: I-Behavioral assessment: -Measurement of levels of activity using the activity cage test: Levels of activity were measured by detecting rat movements using a grid floor activity cage (Model No. 7430; Ugo Basile, Varese, Italy), according to the method described by Pavic et al., [16] .
-Measurement of motor coordination using the rotarod test:
Motor coordination in this study was assessed using an accelerating rotarod (Model No. 7750; Ugo Basile), according to the procedure described by Vijitruth et al., [17] .
-Test for cognitive abilities using T-maze:
Animals were introduced from the base of the T-maze and allowed to choose one of the goal arms abutting the other end of the stem. The trial was carried out thrice in 3 successive days. At the third trial, the rodent tended to choose the arm not visited before, reflecting a memory of the first choice. This is called' spontaneous alternation'. This tendency was reinforced by starving the animal for 24h before the test and rewarding it with a preferred food item if it alternates. Each trial was completed in less than 5 minutes [18] . This step was done at zero time and twenty four hours after the last dose of the tested drugs was given.
II-Biochemical and gene expression tests: -Determination of TNF-(x level in serum:
This assay employs the quantitative sandwich enzyme immunoassay technique. Part of brain tissue was further processed for RNA extraction followed by reverse transcription (RT) and quantitative real time PCR [19] .
-Estimation of the levels of MDA by colorimetry:
The determined values are expressed in terms of malondialdehyde (n mol/mg protein) used as reference standard.
III-Histological and morphometric studies:
-Histological study: The brain sections were stained by hematoxylin and eosin [20] . -Histochemical study: 4 gm paraffin wax sections were stained using congo red stain [21] . -Immunohistochemical study: Estrogen receptor immunostaining: Using the avidin-biotin immunoperoxidase polyclonal kit provided by NEO Marker's (Lab. Vision Corporation) [22] . -Morphometric study.
Using leica qwin 500 LTD image analysis (Cambridge, UK), assessment of the area % of dark nuclei in H&E stained sections and the area % of ER immunoexpression were performed using binary mode.
The area of plaques was determined in Congo red stained sections using interactive measurements menu. The measurements were done in 10 high power fields (HPF) in control and experimental groups.
Statistical analysis of behavioral parameters:
All values of T-maze, rotarod and activity cage tests are presented as means±standard error (mean± S.E.). Square root transformed percent was calculated according to Jones et al., [23] , then comparison between more than two different groups was carried out using the non-parametric one-way analysis of variance (ANOVA) followed by Dunn's multiple comparisons test. Difference was considered significant at p<0.05. [24] .
Statistical analysis of biochemical, gene expression and morphometric parameters:
Data were summarized using mean and standard deviation (mean±SD). Comparisons between groups were done using analysis of variance (ANO-VA) with multiple comparisons Bonferroni post hoc test in normally distributed quantitative variables [25] to detect which pairs of groups caused the significant difference. p-values less than 0.05 were considered as statistically significant.
Results
I-Results of behavioral assessment:
As shown in Table ( 1), in AD group (group II) and in AD+OVX group (group III), the mean value of % change of time in T-maze test was significantly increased compared to control group (group I), however, AD+OVX group (group III) showed no significant change in square root transformed % of time in T-maze test compared to AD group (group II).
In AD+OVX+estrogen replacement group (group IV), square root transformed % of time in T-maze test was significantly decreased compared to AD group (group II), however, it was still significantly increased compared to control group (group I).
In AD+OVX+estrogen and progesterone replacement group (group V), square root transformed % of time in T-maze test showed a significant decrease compared to AD group (group II) and AD+OVX group (group III). However, it showed no significant change compared to AD+OVX+ estrogen replacement group (group IV).
As shown in Fig. (1) , in AD group (group II), square root transformed % of activity in activity cage test was significantly decreased compared to control group (group I), while, in AD+OVX group (group III), there was no significant change compared to control group (group I) and AD group (group II). Estrogen replacement in group (group IV) did not produce any significant change compared to control group (group I), AD group (group II) or AD+OVX group (group III). In AD+OVX +estrogen and progesterone replacement group (group V), square root transformed % of activity in activity cage test showed no significant change compared to control group (group I). Meanwhile, it showed significant increase compared to AD group (group II) and AD+OVX group (group III). However, square root transformed % of activity in activity cage test in AD+OVX+estrogen and progesterone replacement group (group V) showed no significant change compared to AD+OVX+ estrogen replacement group (group IV).
As shown in Table ( 2), in AD group (group II), square root transformed % of duration of rotations in seconds in rotarod test was significantly decreased compared to control group (group I).
In AD+OVX group (group III), the mean value was significantly decreased compared to control group (group I), however, it showed no significant change compared to AD group (group II).
In AD+OVX+estrogen replacement group (group IV) and in AD+OVX+estrogen and progesterone replacement group (group V) square root transformed % of duration of rotations in seconds in rotarod test showed no significant change compared to control group (group I), meanwhile, it showed significant increase compared to AD group (group II). Progesterone replacement did not produce any significant change compared to AD+ OVX+estrogen replacement group (group IV).
II-Results of Biochemical and gene expression tests:
As shown in Table ( 3), serum TNF-(x was significantly elevated in AD group (group II) compared to control group (group I). AD+OVX group (group III) showed significant increase in serum TNF-(x compared to control group (group I) and to AD group (group II).
Serum TNF-(x in AD+OVX+estrogen replacement group (group IV) was significantly elevated compared to control group (group I), while it was significantly decreased compared to AD group (group II) and AD+OVX group (group III). Serum TNF-(x in AD+OVX+estrogen and progesterone replacement group (group V) was significantly increased compared to control group (group I), however, it showed no significant change compared to AD+OVX+estrogen replacement group (group IV).
As shown in Fig. ( 2), seladin-1 gene expression in brain tissue of AD group (group II) was significantly decreased compared to control group (group I).
AD+OVX group (group III) showed significant decrease in Seladin-1 gene expression compared to control group (group I), however there was no significant change compared to AD group (group II).
Seladin-1 gene expression in brain tissue of AD+OVX+estrogen replacement group (group IV) was significantly decreased compared to control group (group I), while it was significantly increased compared to AD group (group II) and AD+OVX group (group III).
Addition of progesterone in group V did not produce any significant change compared to AD+ OVX+estrogen replacement group (group IV).
As observed in Fig. (3) , ER-(x gene expression in brain tissue of AD group (group II) showed no significant change compared to control group (group I). AD+OVX group (group III) showed significant decrease in ER-(x gene expression in brain tissue compared to control group (group I). However, value of ER-(x gene expression in brain tissue of AD+OVX group (group III) showed no significant change compared to AD group (group II). ER-(x gene expression in brain tissue of AD+ OVX+estrogen replacement group (group IV) was significantly increased compared to control group (group I), AD group (group II) and AD+OVX group (group III). ER-(x gene expression in brain tissue of AD+ OVX+estrogen and progesterone replacement group (group V) showed no significant change compared to AD+OVX+estrogen replacement group (group IV).
As observed in Fig. (4) , Bcl-2 gene expression in brain tissue of AD group (group II) was significantly decreased compared to control group (group I). AD+OVX group (group III) showed significant decrease in Bcl-2 gene expression in brain tissue compared to control group (group I), however, there was no significant change compared to AD group (group II).
Estrogen replacement in group IV induced a significant decrease in Bcl-2 gene expression in brain tissue compared to control group, and a significant increase compared to AD group (group II) and AD+OVX group (group III).
Bcl-2 gene expression in brain tissue of AD+OVX+estrogen and progesterone replacement group (group V) was significantly elevated compared to AD group (group II), AD+OVX group (group III) and AD+OVX+estrogen replacement group (group IV).
As shown in Table ( 5), MDA level in brain tissue of AD group (groupII) and in AD+OVX group (group III) was significantly elevated compared to control group (group I). MDA level in brain tissue of AD+OVX group (group III) also showed a significant increase compared to AD group (group II).
Estrogen replacement in group IV induced a significant decrease compared to AD+OVX group (group III), however it showed no significant change compared to AD group (group II).
MDA level in brain tissue of AD+ OVX+estro-gen and progesterone replacement group (group V) showed no significant change compared to AD group (group II) or AD+OVX+estrogen replacement group (group IV).
Role of Estrogen Hormone in Lipopolysaccharide-Induced Histological results:
Examination of H&E stained cerebral sections of control group (group I) revealed the normal architecture of the cerebral cortex which is formed of multiple layers. These layers consisted of neurons and neuropil. Closer observation demonstrated basophilic cell bodies and large pale nuclei of pyramidal neurons. Small cells with dark rounded nuclei were considered neuroglial cells (Fig. 5-A) .
Cerebral sections of rats of AD group (group II) showed an eosinophilic mass surrounded by a vacuolated area among the neurons in most of the fields. Closer observation of sections in the cerebral cortex in AD group (group II) recruited multiple dark nuclei in a large eosinophilic mass surrounded by a vacuolated area in multiple fields. Dark nuclei of some of the surrounding neurons were noticed ( Fig. 5-B ).
In rats of AD+OVX group (group III), sections in the cerebral cortex showed multiple eosinophilic masses each surrounded by a vacuolated area). By close observation of various sections, dark nuclei were found in some eosinophilic masses each surrounded by a vacuolated area.
Dark nuclei of multiple surrounding neurons were evident (Fig. 5-C) .
Sections in the cerebral cortex of rats in AD+OVX+estrogen replacement group (group IV) denoted occasional eosinophilic masses surrounded by a vacuolated area in the different fields. Some dark nuclei were found on close observation in occasional small eosinophilic masses surrounded by a vacuolated area. Few neurons exhibiting dark nuclei were seen surrounding these masses among multiple normal pyramidal neurons (Fig. 5-D) .
Sections in the cerebral cortex of rats in AD+ OVX+estrogen and progesterone replacement group (group V) showed few distended vessels. Few neurons containing dark nuclei were detected among other normal neurons ( Fig. 5-E) .
Histochemical results:
Examination of cerebral sections of control rats (group I) stained with Congo red revealed absence of deposited material (Fig. 5-F) . In AD group (group II) sections showed localized areas of multiple Congo red positive deposited plaques (Fig.  5-G) . In rats of AD+OVX group (group III), sections showed widespread multiple positive Congo red deposited plaques (Fig. 5-H) . These plaques became fewer in cerebral cortex sections belonging to AD+OVX+estrogen replacement group (group IV) (Fig. 5-I) . No obvious plaques could be observed in AD+OVX+estrogen and progesterone replacement group (group V) (Fig. 5-J ).
Immunohistochemical results: ER immunostaining:
Sections in the cerebral cortex of a control rat showed some ER SP1+ve nuclei of neurons ( Fig.  5-K) . In AD group (group II), few ER SP1+ve nuclei were detected (Fig. 5-L) . In AD+OVX group (group III), occasional ER SP1 +ve nuclei were found (Fig. 5-M) . In AD+OVX+estrogen replacement group (group IV), multiple+ve nuclei were usually seen around blood vessels ( Fig. 5-N) . Similarly, in AD+OVX+estrogen and progesterone replacement group (group V), multiple ER SP1 +ve nuclei were noticed ( Fig. 5-O ).
Morphometric results: Area % of dark nuclei:
The mean area % of dark nuclei was measured in haematoxylin and eosin stained cerebral sections. The results indicated a significant increase ( p<0.05) in AD+OVX group (group III) compared to the other groups. In addition, a significant decrease was noted in AD+OVX+estrogen replacement group (group IV) and In AD+OVX+estrogen and progesterone replacement group (group V) compared to the other groups ( Table 6 ).
Area of plaques:
The mean area ( g 2) of plaques was measured in Congo red stained cerebral sections. In AD+OVX group (group III), it was significantly increased compared to control group. In AD+OVX+estrogen replacement group (group IV), the mean area was significantly decreased compared to AD group (group II) and AD+OVX group (group III) ( Table  6 ).
Area % of ER immunoexpression:
The mean area % of +ve ER immunoexpression was measured in cerebral sections of different groups. In AD group (group II), and in AD+OVX group (group III), the mean area % was significantly decreased (p<0.05) compared to the other groups. On the other hand, in AD+OVX+estrogen replacement group (group IV), and in AD+OVX+estrogen and progesterone replacement group (group V), the mean area % was significantly increased (p<0.05) compared to the other groups (Table 6 ). 
*
ER-α gene expression
K-Ccontrol rat (group I) showing some ER SP1 +ve nuclei (arrows) (ER immunostaining, x400). L-AD group (group II) showing few ER SP1 +ve nuclei (arrows) (ER immunostaining, x400). M-AD+OVX group (group III) showing occasional ER SP1 +ve nuclei (arrows) (ER immunostaining, x400). N-AD+OVX+estrogen replacement group (group IV) showing multiple ER SP1 +ve nuclei (arrows). Note a vessel (v)
(ER immunostaining, x400). 
Discussion
In the present study, LPS injection induced AD was manifested by impairment in memory as detected by T-maze test, impairment of activity as detected by activity cage test and impairment of motor coordination as detected by rotarod test. This was through induction of inflammation, oxidative stress, deposition of Aß plaques, reduction in Seladin-1, ER-(x and anti-apoptotic protein Bcl-2. Ovariectomy was performed before the Induction of AD aggravated the condition.
In the current work, in AD group (group II) and in AD+OVX group (group III), square root transformed % of time in T-maze test was significantly increased compared to control group (group I). The results of AD+OVX+estrogen replacement group (group IV) significantly decreased the square root transformed % of time in the T-maze compared to AD group (group II) and AD+OVX group (group III). It can be seen from the results of this work that E2 maintains healthy cognitive function and protect against cognitive decline in females during aging.
It is suggested that estradiol may interact with the cholinergic function in the hippocampus to modulate learning and memory [26] . Prefrontal cortex (PFC) may be another important target for steroid hormones' effects on cognitive performance [27] .
This result is in agreement with a study on an aluminum chloride (AlCl3)-induced AD rat model that showed significant increases in the time taken by rats to reach the food in the T-maze behavior stress test for the groups of rats given AlCl3 for 4 successive weeks (AD group) [28] . Also, Heikkinen et al., [29] reported that at the age of 7 months, the OVX mice performed inferior to sham mice in the T-maze task and that E2 administration enhances performance in T-maze.
In accordance, Davis et al., [30] reported that when E2 is administered to OVX rats, performances in hippocampally-mediated tasks are improved over that produced by vehicle administration. Janicki et al., [31] recorded that gene variants that affect estrogen activity are associated with risk for AD.
In the AD group (group II), both the square root transformed % of activity in activity cage test and square root transformed % of duration of rotations in seconds in rotarod test were significantly decreased compared to control group (group I). AD+OVX+estrogen replacement group (group IV) square root transformed % of activity in activity cage test showed no significant change compared to control group (group I). This means that estrogen replacement completely reversed the LPS-induced AD effect on square root transformed % of activity in activity cage test.
This result was in agreement with Ohtani et al., [32] that found that chronic estrogen treatment has been shown to reverse OVX-induced decrease in locomotor activity in adult Sprague-Dawley rats.
In the current work, AD and AD+OVX group (group III) showed significant increases in serum TNF-(x compared to control group (group I) and that serum TNF-(x in AD+OVX group (group III) was significantly increased compared AD group (group II). Estrogen replacement in group (group IV) significantly decreased serum TNF-(x compared to AD group (group II) and AD+OVX group (group III). This result is in agreement with Spinedi et al., [33] , who reported that ovariectomy has been shown to significantly enhance endotoxin-induced TNF-(x release in mice.
Estradiolic compounds have shown anti inflammatory activity [34] ; decreased production of proinflammatory cytokines such as IL-6, IL-1 ß, and TNF-(x which promoted activity and expression of acetylcholinesterase (AchE) [35] .
In agreement, Abu-Taha et al., [36] found that pro-inflammatory cytokine production increases in several injury models in both the central nervous system (CNS) and the periphery in postmenopausal women compared with their premenopausal counterparts and in young and middle-aged rodents subjected to ovariectomy [37] , thereby contributing to a chronic, subclinical state of inflammation that may contribute to neurodegeneration and cognitive decline [38] . Also, Vegeto et al., [39] showed a major antiinflammatory activity of estradiol in microglia activated by strong inflammatory stimuli such as LPS. This effect was antagonized by ICI 182, 7 80, an estrogen receptor antagonist, suggesting a receptor-mediated effect of the hormone and ER-_ appeared to be selectively involved in estradiol anti-inflammatory activity in brain macrophages [40] . Using ER-null mice several reports described the selective involvement of ER-(x in the antiinflammatory and neuroprotective activity of estradiol against neuroinflammatory and vascular pathologies of the brain [40] . An estrogen inhibitory element was mapped to the TNF-(x promoter [41] , which might explain the inhibitory effect of estrogens on the expression of TNF-(x in target cells [42] .
On the other hand, Bruce-Keller et al., [43] and Colton [44] found that treatment of brain macrophages and peripheral macrophages with E2 reduces the TNF-(x production.
In the present study, in AD group (II), histopathological sections showed marked degenerative changes, which was confirmed by a significant increase in the mean area % compared to the other groups. Overk et al., [45] concluded that gonadectomy aggrevated hippocampal AD-like pathology in male and female mice. Su et al., [46] proved that ovariectomy impaired spatial memory and led to morphological changes in cognitive centers of rat brain. Kaliyamurthi et al., [47] suggested a central hypothesis in the study of AD is the accumulation and aggregation of A beta peptide and that ovariectomized animals were more susceptible to AD with significant increase in A beta peptide.
The Aß 1-42 aggregate is one of the major constituents of senile plaques in the brain regions subserving memory and cognition, and plays a causative role in the neuronal degeneration and memory loss seen in AD patients. Amyloid-ß plaques (Aß 1-42) significantly reduced brain acetylcholine level leading to hippocampal Ach reduction accompanied by memory impairment [48] . Moreover Aß 1-42 is neurotoxic [49] , and impairs spatial working memory [50] and cognitive responding [51] . Aß 1-42 could also influence memory indirectly by triggering an inflammatory response which has a detrimental effect on synaptic function and memory [52] . Assembled Aß in the form of soluble oligomers and insoluble fibrils can induce neuronal death [53] and synaptic disruption [54] leading to impaired learning and memory [55] .
In the present study, AD+OVX+estrogen replacement group (group IV) denoted occasional eosinophilic masses surrounded by a vacuolated area. Some dark nuclei were found surrounded in these masses surrounded. Few surrounding neurons exhibited dark nuclei. In agreement, Chang et al., [56] reported mitochondrial morphological changes that may explain the increased prevalence of cognitive decline associated with aromatase inhibitor use. Dong et al., [57] postulated that DNA protection may be mediated by estrogen.
The current results showed that the amyloid plaques became fewer in cerebral cortex sections belonging to AD+OVX+estrogen replacement group (IV), confirmed by a significant decrease in the mean area of plaques. In accordance with the current study, in diverse animal models of Alzheimer's disease, estrogen has prevented or delayed the development of Alzheimer's disease pathology in particular Amyloid ß accumulation and plaque formation [58] . E2 regulation of Aß has been observed in several transgenic mouse models of AD; that is, OVX is associated with increased Aß and E2 treatment with reduced Aß levels [59] . Estrogen may regulate the production of Amyloid ß and in turn, sustain an improved Amyloid ß homeostasis by Increasing the metabolism of amyloid precursor protein and destabilization of Amyloid ß fibrils. In vitro estrogen treatment inhibited the formation of toxic Amyloid ß oligomers [60] . Moreover, a potential role for estrogen in the regulation of secretase expression and/or activity was suggested [12] .
Estrogen activated Neprilysin, the primary enzyme that degrades Amyloid ß, thereby facilitating Amyloid ß degradation in human neuroblastoma cells [61] . E2 has been linked to increased expression of Neprilysin in rat brain [62] . Amyloid _ oligomer inhibited the activity of calcium/ calmodulin dependent protein kinase II and extracellular signal-regulated kinase in a manner ameliorated by estrogen treatment [63] . Anastasio (2013) [64] stated that estrogen influences the Aß-regulation system and consequently denotes therapeutically relevant predictions.
Contradictory to the present results, estrogen levels were found to be associated with Aß accumulation only in some but not all transgenic mouse models of AD [65] . Discrepancies in the effects of estrogen on Aß levels across transgenic mouse models may reflect several differences, ranging from molecular design of the transgenic lines to variability in methodological parameters such as the timing and dosing of hormone manipulations [60] .
In the present work, Seladin-1 gene expression in brain tissue of AD group (group II) and in AD+ OVX group (groupIII) was significantly decreased compared to control group (group I). Estrogen replacement in group IV significantly increased Seladin-1 gene expression in brain tissue compared to AD group (group II) and AD+OVX group (group III).
Butler and Kadonaga [66] indicated that the Seladin-1 gene transcription is activated, upon exposure to 17ßE2 through a direct interaction of ER-(x with the half-palindromic EREs located upstream from the Seladin-1 gene promoter. Estradiol may increase Seladin-1 expression by promoting the release of IGF-1, which enhances Seladin-1 synthesis. Peri et al., [67] proposed that the neuroprotective mechanism of Seladin-1 may involve an increased synthesis of cholesterol and its consequent metabolism to neuroprotective steroids. The neuroprotective effect of Seladin-1 appears to be mediated, in part, by its inhibitory effect on the activation of caspase-3, a key mediator of apoptosis [68] .
These data are consistent with the study of Greeve et al., [69] , in which expression levels of this gene are low in AD brains. In cell culture, increased Seladin-1 expression was protective against Aß toxicity and oxidative stress-induced apoptosis [70] . Thus, in the present study, the accumulation of Aß may be due in part to the low levels of Seladin-1.
LPS injection in AD group (groupII) produced a non-significant decrease in ER-(x gene expression in brain tissue compared to control group (group I). Also, few ER SP 1 +ve nuclei were detected and the mean area% of ER immunoexpression indicated a significant decrease compared to group I.
An immunohistochemical study showed that ER-(x was observed in the hippocampus of elderly human controls and was decreased in AD patients suggesting the presence of nuclear ER-(x in hippocampal neurons seemed to protect against the formation of AD changes [71] .
Also in the current work, in AD+OVX group (III), occasional ER SP1+ve nuclei were found and in AD+OVX+estrogen replacement group (IV), multiple +ve nuclei were usually seen around blood vessels and in AD+OVX group (III), the mean area % of ER immunoexpression indicated a significant decrease compared to the other groups while in AD+OVX+estrogen replacement group (IV) it denoted a significant increase compared to the other groups.
Previous studies on the regulatory effect of external estrogen on ER expression in brain revealed different results. Honjo et al., [72] reported that 17ß-estradiol decreased ER-(x mRNA levels in the hypothalamus of ovariectomized rats. 17ß-estradiol was also shown to down-regulate the levels of ER-(x immunoreactivity in hippocampus of both male and female rats [73] .
On the other hand, Mitchner et al., [74] found that ER-(x and ER-(x mRNA expression in SpragueDawley rat pituitary tissue was not changed after treatment with estradiol. Estradiol benzoate (EB) administration was shown to induce a significant time-dependent decrease in ER-(x and ER-(x mRNA levels of the adult rat pituitary gland.
It was also found that the hypothalamic expression of ER-(x and ER-(x mRNA was increased after acute exposure to EB in pre-pubertal male rats [75] . Jin et al., [76] found that an estrogenic ligand might up-or down-regulate estrogen receptors, depending on the tissue and physiological conditions and that different estrogen preparations have distinct estrogenic effects on target organs. Winkler and Fox [77] added that ER are considered as key components and regulators of the disrupted homeostatic processes controlling gene expression, apoptosis, and protein synthesis, disrupted during AD. Schreihofer and Ma [78] suggested that changes in ER expression and location that may underlie the loss of E2 neuroprotection seen with aging and long-term estrogen deprivation.
In the present work, Bcl-2 gene expression in brain tissue of AD group (group II) and in AD+OVX group III, was significantly decreased compared to control group (group I). Bcl-2 gene expression in brain tissue of AD+OVX+estrogen replacement group (group IV) was significantly increased compared to AD group (group II) and AD+OVX group (group III).
Stimuli for apoptosis in AD include increased oxidative stress, dysregulation of ion homeostasis, growth factor deprivation, accumulation of Aß, metabolic impairment, reduced clearance of toxin, mitochondrial dysfunction, DNA damage and protein aggregation [79] .
In accordance with the present work, Johnson et al., [80] and Ohyagi et al., [81] reported that amyloid ß could activate protein 53 (p53) by direct interaction with the p53 promoter which led to Bax and caspase-6 activation with subsequent reduction of Bcl-2 and execution of the cell death pathway.
Similarly, Sharma and Mehra [82] stated that ovariectomy decreased Bcl-2 expression and increased proapoptotic marker (Bax) expression in the rat hippocampus.
This result was in accordance with Nilsen and Brinton [83] who stated that estrogen markedly upregulates Bcl-2 expression in primary cultured hippocampal neurons. Also, Nilsen and Brinton [84] demonstrated that estrogen increases antiapoptotic proteins, Bcl-2 and B cell lymphomaextra large (Bcl-xl), which prevent the activation of the permeability transition pore and thereby protect against the mitochondrial Ca2+accumu-lation. Estradiol can directly upregulate this survival factor through receptor-mediated interactions with regions of the Bcl-2 promoter, which contains several putative estradiol responsive sites [85] . The observed effects of E2 on Aß mediated apoptosis were found to be mediated via ER dependent mechanisms, since the anti-apoptotic effects of E2were blocked by pre-treatment with an ER antagonist [86] . Supporting this, it has been previously demonstrated that both ER-(x and ER-(x are crucial in regulating Bcl-2 expression and neuronal survival [87] and it has been shown that E2 can also increase Bcl-2 through Akt-dependent cAMP response element-binding protein (CREB) activation [88] . ERs can interact directly with the MAPK pathway resulting in the activation of a wide variety of transcription factors involved in neuronal survival [89] . Notably, MAPK signaling is accompanied by the activation of cAMP response element-binding protein (CREBP), the induction of Bcl-2 expression, and the inhibition of the apoptotic cascade [90] . Estrogen receptors can also interact with the Phosphatidylinositide 3-kinase (PI3K) signaling pathway leading to activation of the effector protein kinase Akt. Activated Akt, in turn, can modulate the expression of apoptosis inhibitors (i.e., Bcl-2 and Bcl-x) or inducers [i.e., Bax and Bcl-2-associated death promoter (Bad)], thus influencing cell death.
Similarly, phosphorylation of either caspase-9 or the fork head transcription factors by Akt could further block the apoptosis induction in neurons. Therefore, Akt promotes cell survival opposing to the apoptosis by a variety of routes [89] .
The results of the present work showed that MDA level in brain tissue of AD group (groupII) and group III AD+OVX was significantly elevated compared to control group (group I). Similarly, increased levels of MDA have been identified early in the course of the disease in the vulnerable superior and middle temporal gyri of the Alzheimer brain. MDA levels have even been found increased in these regions in patients with minimal cognitive impairment, a condition that often precedes AD [91] . Activated glial cells have the potential to produce large amounts of reactive oxygen species/nitrogen species by various mechanisms [92] . Aß progressively accumulates in brain mitochondria of Alzheimer's patients and transgenic mouse model of AD, exerting a deleterious effect on mitochondrial function, including energy failure, altered mitochondrial properties, and elaboration of ROS [93] .
Amyloid-binding alcohol dehydrogenase (ABAD) is a mitochondrial enzyme which binds Aß in the nanomolar range, and potentiates Aß-induced cell stress. ABAD is elevated in the cerebral cortex and hippocampus of AD affected brain regions and in mouse models of AD [94] . Overexpression of ABAD exacerbates Aß-mediated mitochondrial and neuronal dysfunction, as evidenced by reduced enzyme activity associated with complex IV in the respiratory chain, diminished oxygen consumption, decreased brain glucose utilization, decreased ATP, and leakage of mitochondrialderived ROS [93] .
Similarly, Yalin et al., (2006) [95] found that the level of MDA an end product of lipid peroxidation is found to significantly increase in the various tissues of OVX rats. Oxidative stress may be increased in menopausal women owing to a hyperproduction of ROS or a deficiency in the anti-oxidant defense system. Impaired radical scavenger function has been linked to the decreased activity of enzymatic and non enzymatic scavengers [96] . In particular, the action of Superoxide Dismutase (SOD) has been found to be decreased in the various tissues of OVX rats [95] . Similarly, a reduction in the action of the Glutathione Peroxidase (GSH-Px) and Catalase (CAT) has been observed [96] .
The results of the current study showed that MDA level in brain tissue of AD+OVX+estrogen replacement group (group IV) was significantly decreased compared to AD+OVX group (group III). In agreement, Ulas and Cay [96] stated that E2 and its derivates are strong endogenous antioxidants that reduce lipid peroxidation levels in brain. Also, Yalin et al., (2006) [95] found that the level of MDA as an end product of lipid peroxidation is found to significantly increase in the various tissues of OVX rats.
Oxidative stress may be increased in menopausal women owing to a hyperproduction of ROS or a deficiency in the anti-oxidant defense system. Impaired radical scavenger function has been linked to the decreased activity of enzymatic and non enzymatic scavengers [96] . In particular, the action of SOD has been found to be decreased in the various tissues of OVX rats [95] .
Similarly, a reduction in the action of the GSHPx and CAT has been observed. Estrogens can induce anti-oxidant enzyme expression by stimulating the anti-oxidant defense system and inhibiting the formation of lipid peroxides in tissues in vitro [96] . Noh et al., [97] observed that estrogen replacement in OVX rats produces a marked increase in the serum level of vitamin E. In particular, E2 displays neuroprotection against Aß amyloid toxicity [98] and oxidative stress-induced neuronal death [99] in many neuronal cell lines and tissue preparations. Moreover, E2 seems to protect neurons against apoptosis by reducing ROS production [100] , maintaining the Ca2+ homeostasis [101] , regulating pro-apoptotic caspase activities [102] , and maintaining mitochondrial membrane integrity [103] . E2 rapidly promotes the phosphorylation and the subsequent inactivation of the voltage dependent anion channel (VDAC), a mitochondrial porin also found at the neuronal membrane, where it appears to be involved in redox regulation and Aß amyloid neurotoxicity. This E2 effect requires the activation of PKA and non-receptor protein tyrosine kinase (Src-kinase) which may be relevant to maintain this channel inactivated [104] .
To investigate if this protective effect of estrogen can be modulated by progesterone, the OVX rats were replaced with both estrogen and progesterone. The square root transformed % of time in T-maze test in AD+OVX+estrogen and progesterone replacement group (group V) showed significant decrease compared to AD group (group II) and AD+OVX group (group III). In accordance, E2 and E2 plus progesterone replacement was associated with improved spatial memory
In the present work, in AD+OVX+estrogen and progesterone replacement group (V) distended vessels and few neurons containing dark nuclei were detected among other normal neurons. No obvious plaques could be observed in this group. Multiple ER SP 1 +ve nuclei were noticed also in this group and area % of ER immunoexpression showed significant increase compared to the other groups.
These results provide new insight into the neural interactions between estradiol and progesterone that may optimize hormone therapy regimens in postmenopausal women. The enhancement of the estrogen protective effect on LPS-induced AD after concomitant progesterone replacement suggests either a direct protective role of progesterone or an indirect action by potentiation of one or more of estrogen protective pathways.
It can be concluded that AD produced cognitive dysfunction. It also produced decrease in motor activity and coordination. This was produced in the present study by increase in inflammation (evidenced by increase in serum TNF-(x), apoptosis (evidenced by increase in area % of dark nuclei and decrease in anti-apoptotic Bcl-2 gene expression in brain tissue), oxidative stress (as demonstrated by increase in MDA level in brain tissue), decrease in ER-(x in brain tissue (as demonstrated by decrease in area % of ER immunoexpression) and deposition of amyloid plaques (as demonstrated by increase in area of plaques). Also it was found that OVX aggravated AD. Furthermore, current results showed that estrogen replacement provided partial improvement in the cognitive dysfunction and complete reversal of the deterioration in motor activity and motor coordination suggesting that this effect was through decrease in amyloid plaque deposition, anti-inflammatory, anti-oxidant and antiapoptotic mechanisms partially via increase in ER-(x expression. This was further improved by combined estrogen and progesterone supplementation. Progesterone co-administration further improved cognitive and motor functions suggesting a direct neuroprotective role of progesterone or indirect action through estrogen.
We recommend further studies to clarify the effect of estrogen in other patho-physiological pathways of AD e.g. glutamate excitotoxicity. Also, effect of progesterone replacement alone and cyclic versus continuous use of progesterone in combination with estrogen in AD needs further studies to be assessed. Finally, effect of phytoestrogens on AD needs to be studied
